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Signaling cascades initiated by nitric oxide (NO) are cru-
cial in the physiology and pathophysiology of the cardio-
vascular system. NO signal is mediated by the soluble
guanylyl cyclase (sGC), which is a heme-containing het-
erodimer that produces cGMP. In spite of its importance,
little is known about the mechanisms of regulation of
sGC, even though dysfunctions in the NO-cGMP signal-
ing pathway are thought to be responsible for diseases as
prevalent as hypertension and atherosclerosis. In particu-
lar, the mechanism of desensitization of sGC remained
unresolved. Desensitization of sGC is the loss of sGC acti-
vation by NO following an initial exposure to NO.
Post-translational modification has been postulated to
affect sGC sensitivity to NO but evidence is still lacking.
We show here, that sGC is S-nitrosylated and that this S-
nitrosylation results in decreased responsiveness to NO
characterized by the loss of NO-stimulated sGC activity.
Using primary aortic smooth muscle cells and S-nitroso-
cysteine (CSNO), we provide evidence that desensitiza-
tion of sGC is concentration and time dependent, and
that sensitivity of sGC to NO is restored, and S-nitrosyla-
tion reverses with cellular increase of thiols. We con-
firmed in vitro using semi-purified sGC and peroxynitrite
that S-nitrosylation directly causes desensitization, sug-
gesting that other cellular factors might not be involved.
By using Mass Spectrometry, we have identified two
cysteines, one in each subunit that are potentially S-
nitrosylated. Replacement of these cysteines with Alanine
created mutants that were mostly resistant to desensitiza-
tion. This study suggests that S-nitrosylation of sGC could
be a mean by which memory of NO exposure is kept in
smooth muscle cells.
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